SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Staels B)
 

Search: WFRF:(Staels B) > (2010-2014) > SULF2 Strongly Pred...

  • Hassing, H. C. (author)

SULF2 Strongly Prediposes to Fasting and Postprandial Triglycerides in Patients with Obesity and Type 2 Diabetes Mellitus

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • 2014-01-09
  • Wiley,2014

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/199645
  • https://gup.ub.gu.se/publication/199645URI
  • https://doi.org/10.1002/oby.20682DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Objective: Hepatic overexpression of sulfatase-2 (SULF2), a heparan sulfate remodeling enzyme, strongly contributes to high triglyceride (TG) levels in obese, type 2 diabetic (T2DM) db/db mice. Nevertheless, data in humans are lacking. Here, the association of human hepatic SULF2 expression and SULF2 gene variants with TG metabolism in patients with obesity and/or T2DM was investigated. Methods: Liver biopsies from 121 obese subjects were analyzed for relations between hepatic SULF2 mRNA levels and plasma TG. Associations between seven SULF2 tagSNPs and TG levels were assessed in 210 obese T2DM subjects with dyslipidemia. Replication of positive findings was performed in 1,316 independent obese T2DM patients. Postprandial TRL clearance was evaluated in 29 obese T2DM subjects stratified by SULF2 genotype. Results: Liver SULF2 expression was significantly associated with fasting plasma TG (r = 0.271; P = 0.003) in obese subjects. The SULF2 rs2281279(A>G) SNP was reproducibly associated with lower fasting plasma TG levels in obese T2DM subjects (P < 0.05). Carriership of the minor G allele was associated with lower levels of postprandial plasma TG (P < 0.05) and retinyl esters levels (P < 0.001). Conclusions: These findings implicate SULF2 as potential therapeutic target in the atherogenic dyslipidemia of obesity and T2DM.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Surendran, R. P. (author)
  • Derudas, B. (author)
  • Verrijken, A. (author)
  • Francque, S. M. (author)
  • Mooij, H. L. (author)
  • Moens, S. J. B. (author)
  • t Hart, L. M. (author)
  • Nijpels, G. (author)
  • Dekker, J. M. (author)
  • Williams, Kevin Jon,1956Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine (author)
  • Stroes, E. S. G. (author)
  • Van Gaal, L. F. (author)
  • Staels, B. (author)
  • Nieuwdorp, Max (author)
  • Dallinga-Thie, G. M. (author)
  • Göteborgs universitetInstitutionen för medicin, avdelningen för molekylär och klinisk medicin (creator_code:org_t)

Related titles

  • In:Obesity: Wiley22:5, s. 1309-13161930-73811930-739X

Internet link

Find in a library

  • Obesity (Search for host publication in LIBRIS)

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view